Exagen (XGN) Capital Expenditures Growth (3y) (2021 - 2026)
Exagen (XGN) Capital Expenditures Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | -6.36% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -3.77% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | -12.74% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 10.06% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 24.83% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -8.17% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | -9.93% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -9.11% |
| 10 | Exagen | 102.82 Mn | 81.30 Mn | 10.21 Mn | -16.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.81% |
| Dec 31, 2025 | 15.40% |
| Sep 30, 2025 | -32.89% |
| Jun 30, 2025 | -52.47% |
| Mar 31, 2025 | -52.98% |
| Dec 31, 2024 | -35.73% |
| Sep 30, 2024 | 49.49% |
| Jun 30, 2024 | 42.50% |
| Mar 31, 2024 | 25.03% |
| Dec 31, 2023 | -47.15% |
| Sep 30, 2023 | 35.72% |
| Jun 30, 2023 | 127.78% |
| Mar 31, 2023 | 120.38% |
| Dec 31, 2022 | 45.45% |
| Sep 30, 2022 | 660.30% |
| Jun 30, 2022 | 75.02% |
| Mar 31, 2022 | 349.11% |
| Dec 31, 2021 | 39.41% |